Chart of Day: Viking Therapeutics (VKTX) – 10/31

In just a few days, Obesity Week 2024 will kick off in San Antonio, Texas.

In fact, the “preeminent international conference for obesity researchers and clinicians, Obesity Week is home to the latest developments in evidence-based obesity science: cutting-edge basic and clinical research, state-of-the-art obesity treatment and prevention, and the latest efforts in advocacy and public policy,” says The Obesity Society.

It’s also where some of the top obesity companies will present their latest data.

Look at Viking Therapeutics (SYM: VKTX), for example.

vktx

The company is set to provide results from its Phase 2 VENTURE clinical trial with its subcutaneous formulation of VK2735. It’s other presentation will highlight results from its Phase 1 multiple ascending dose clinical trial of its oral formulation of VK2735.

From its last traded price of $73.35, we’d like to see VKTX rally back above $90 a share.

deal of the month

best growth stocks

Alliance

Bundle package – lifetime subscriptions for all products

Categories

Recent posts

Tags

Connect with Us

Get FREE Daily Stock Tips

Join and receive market insider stock picks, trade alerts and unique investing insights
This field is for validation purposes and should be left unchanged.
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.

Join Waitlist

We’re sorry, but due to the popularity of our services, we have reached our max number of subscribers and are not currently accepting more. If spots become available, we will be sure to contact you. Please join the waitlist below.
Thank You!

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.